Global Acromegaly Market - Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Apr 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Acromegaly Market By Diagnosis (GH & IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Others), Complications (Local, Systemic, Others),  Treatment (Medication, Surgery, Radiation, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027.

Acromegaly Market

Market Analysis and Insights: Global Acromegaly Market

Acromegaly market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned forecast period. Rising prevalence of hormonal disorder worldwide and emerging markets are the factors responsible for the growth of this market.

Growing cases of hormonal disorder and pituitary gland disorders drives the acromegaly market. Due to increased cases pituitary tumors and nonpituitary tumors will boost up the acromegaly market growth. Moreover, increased prevalence of pituitary tumors and chronic disorders such as carney complex and development of the novel therapy for treatment will boost up the acromegaly market. However, lack of diagnosis, treatment & patient’s awareness of diseases in developing countries and stringent FDA guidelines for the approval of new treatment or drugs may hamper the global acromegaly market.

Acromegaly is the rare hormonal disorder that develops when the pituitary gland produces too much growth hormone during the puberty and adulthood. Growth hormone produced by pituitary gland and secreted into the bloodstream, it will trigger the liver to produce hormone called insulin-like growth factor-I (IGF-I), in turn to that GF-I stimulates the growth of bones and other tissues. If overproduction of growth hormone occurs, excessive amounts of IGF-I stimulated can result growth of soft tissues and skeleton. Acromegaly usually affects middle aged adults, although it can affect or develop at any age. Acromegaly condition sometimes takes a long time to recognize due to this it can cause some serious problems and may even become life-threatening. Symptom of acromegaly includes bones increase in size, enlarged hands and feet, coarsened, enlarged facial features, skin tags, fatigue and muscle weakness, husky voice, erectile dysfunction.

This acromegaly market report provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Acromegaly Market Scope and Market Size

The acromegaly market is segmented on the basis of diagnosis, complications, treatment, route of administration, end-users and distribution channel.

  • On the basis of diagnosis, the acromegaly market is segmented into GH & IGF-I measurement, growth hormone suppression test, imaging and others 
  • On the basis of complications, the acromegaly market is segmented into local, systemic and others. Systemic complications further divided into CNS, CVS, respiratory, endocrine & metabolic, neoplastic, skeletal and others
  • On the basis of treatment, the acromegaly market is segmented into, medication, surgery, radiation and others. Treatment by medication further segmented into somatostatin analogues, dopamine agonists, growth hormone antagonist and others
  • Route of administration segment of acromegaly market is segmented into oral, parenteral and others
  • On the basis of end-users, the acromegaly market is segmented into hospitals, specialty clinics and others.
  • On the basis of distribution channel, the acromegaly market has also been segmented into hospital pharmacy, retail pharmacy others

Acromegaly Market Country Level Analysis

Acromegaly market is analysed and market size information is provided by country, diagnosis, complications, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the acromegaly market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, U.A.E, Egypt, Saudi Arabia, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America holds the largest market share due to increased high prevalence of pituitary tumor and increased healthcare expenditure. Asia-Pacific is expected to account for the largest market share over coming years for the acromegaly market due to increased hormone related disorders & surgeries and rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Acromegaly market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Acromegaly Market Share Analysis

Acromegaly market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acromegaly market.

The major players covered in the acromegaly market are Novartis AG, Sun Pharmaceutical Industries Ltd, Mylan N.V., Teva Pharmaceutical Industries Ltd., Fresenius Kabi USA, Ipsen Group., Zydus Pharmaceuticals, Inc., and Pfizer Inc. among others.

Customization Available: Global Acromegaly Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions